# OnCo record pd-l1-ic-score (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/pd-l1-ic-score/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "pd-l1-ic-score" ;
  schema:name "PD-L1 IC score (immune-cell score, SP142)"@en ;
  schema:alternateName "PD-L1 IC"@en, "IC score"@en, "immune cell score"@en, "tumor-infiltrating immune cell score"@en, "SP142 IC"@en, "IC >= 1%"@en, "IC >= 5%"@en, "IC >= 10%"@en, "IC≥1%"@en, "IC2/3"@en ;
  schema:description "The IC score measures how much of the tumour area is covered by PD-L1-stained immune cells rather than tumour cells. It belongs to the SP142 assay used with atezolizumab and is read differently from every other PD-L1 score."@en ;
  schema:url <https://onco.cc/biomarkers/pd-l1-ic-score/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fa682c9-a312-4932-9831-f286908660ee> ;
  onco:tag "biomarker", "pd-l1" ;
  onco:related <https://onco.cc/biomarkers/pd-l1-cps/>, <https://onco.cc/biomarkers/pd-l1-tps/>, <https://onco.cc/biomarkers/pd-l1-tc-score/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/ventana-pd-l1-sp142/> ;
  onco:terms <https://onco.cc/terms/pd-l1-testing/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/tils/> .